Read more at CNBC.
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Date: | |
Tag: | European Union |
Sort by
Filter
Date
Items per page
-
Ozempic and Wegovy Have Health Benefits Beyond Weight Loss
The effects of semaglutide drugs won’t just be cosmeticThe New York Times - Top stories -
Sanders launches investigation into 'unacceptable' diabetes, weight loss drug prices
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo Nordisk’s respective diabetes and weight loss drugs, ...The Hill - Politics -
How one state is trying to make weight loss drugs cheaper
Weight loss drugs aren't covered by insurance for North Carolina's state employees. The state is negotiating with drugmakers Eli Lilly and Novo Nordisk to try to lower the costs.NBC News - Top stories -
Insurers scale back reimbursements for drugs used for weight loss
A growing number of insurance carriers say they won't cover the cost of weight loss medications because it is too high. The change is forcing some patients to take desperate measures. NBC News' Erin McLaughlin reports.NBC News - Top stories -
What do weight loss drugs mean for a diet industry built on eating less and exercising more?
New weight loss drugs are reshaping a dieting industry built on eating less and exercising moreABC News - Health -
What do weight loss drugs mean for a diet industry built on eating less and exercising more?
New weight loss drugs are reshaping a dieting industry built on eating less and exercising moreABC News - Health -
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Before insurance, Novo Nordisk charges about $1,000 per month for Ozempic in the United States. In Germany, the company charges $59 per month for the same drug.CNBC - Business -
Sanders locks onto next drug pricing target: Ozempic
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Sanders locks onto next drug pricing target: Ozempic After successfully getting manufacturers to lower the prices of insulin and inhalers, Sen. Bernie Sanders ...The Hill - Politics -
Russian court orders seizure of $440mn from JPMorgan
Move follows lawsuit from state-owned bank VTB to recover funds held at America’s largest lenderFinancial Times - Business - Russia -
Russian court orders seizure of $440mn from JPMorgan
Move follows lawsuit from state-owned bank VTB to recover funds held at America’s largest lenderFinancial Times - Business - Russia
More from CNBC
-
Morgan Stanley banker sees 10 to 15 more tech IPOs in 2024, and a 'better year' in 2025
Morgan Stanley, which led the Reddit and Astera Labs IPOs, expects 10 to 15 more tech offerings this year and a "better year" in 2025.CNBC - Business -
Biden administration faces onslaught of lawsuits as business groups claim regulatory overreach
The Biden administration faces a wave of lawsuits targeting its regulatory agenda, as business groups argue federal agencies are overstepping their authority.CNBC - Business - Joe Biden -
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
The decision is another win for the Biden administration in a bitter legal fight with several drugmakers over the constitutionality of the price talks.CNBC - Business -
DJT: Why Trump Media shares closed more than 12% higher
Trump Media, trading under the DJT ticker, has more than doubled in share price during the criminal trial of majority shareholder Donald Trump.CNBC - Business - Donald Trump -
Tesla jumps 15% after passing key hurdle to roll out advanced driver-assistance tech in China
Shares of Tesla rose sharply after the company passed a significant milestone to roll out its advanced driver-assistance technology in China.CNBC - Business - China